HomeVoluMetrix

VoluMetrix

VoluMetrix Reports NIVA|HF for Heart Failure Patients Designated as Breakthrough Device by U.S. FDA

As a Breakthrough Device, NIVA|HF will receive pre-market developmental assistance and prioritized regulatory review from FDA. NIVA|HF is the first application of VoluMetrix's proprietary venous waveform technology.